Le Lézard
Classified in: Science and technology
Subjects: Photo/Multimedia, Contract/Agreement, Product/Service

Iteris Selected by City of Suffolk, VA for Traffic Signal Timing Engineering Services


Iteris, Inc. (NASDAQ: ITI), the global leader in smart mobility infrastructure management, today announced that it has been awarded an open-ended annual services on-call contract by the City of Suffolk, Virginia's Department of Public Works for traffic signal optimization engineering services, representing continued demand for Iteris' specialized consulting services in a key geographic market.

Under the contract, which is renewable for an additional four years with an estimated potential value of up to $1 million, Iteris will develop signal timing plans for key signalized intersections, provide vehicle turn movement counts, perform before-and-after corridor analysis, develop hurricane evacuation timing plans and Interstate 664 diversion timing plans, and design intelligent transportation system (ITS) equipment plans. The City of Suffolk encompasses 1,600 roadway miles for which Iteris' ITS experts will support traffic management operations, emergency planning and operations, and the deployment of new technologies.

In support of the City of Suffolk's goals of planning, delivering, operating and maintaining a transportation system that is safe, connected and environmentally sensitive, Iteris will identify innovative approaches and cost-effective traffic signal retiming techniques to improve safety and mobility, reduce stops and traffic congestion, and increase sustainability. By reducing delays and stops on key corridors for passenger vehicles and heavy vehicles, the City of Suffolk's signal timing program will help to reduce CO2 emissions and fuel consumption, which in turn will contribute to environmental and air quality improvements.

"We are proud to be selected by the City of Suffolk to support another important mobility infrastructure project in the Commonwealth of Virginia," said Jeff Gerken, regional vice president, Consulting Solutions at Iteris. "This traffic signal timing program represents the continued expansion of Iteris' specialized consulting services in the Mid-Atlantic, and will ultimately help to increase safety and mobility for the city's traveling public, while also improving air quality and reducing fuel consumption."

Iteris has designed, deployed or equipped over one third of all signalized intersections in the United States, supporting local and state transportation agencies with advanced detection sensors, and traffic signal design, timing and synchronization services.

About Iteris, Inc.

Iteris is the global leader in smart mobility infrastructure management ? the foundation for a new era of mobility. We apply cloud computing, artificial intelligence, advanced sensors, advisory services and managed services to achieve safe, efficient and sustainable mobility. Our end-to-end solutions monitor, visualize and optimize mobility infrastructure around the world to help ensure that roads are safe, travel is efficient, and communities thrive. Visit www.iteris.com for more information, and join the conversation on Twitter, LinkedIn and Facebook.

Iteris Forward-Looking Statements

This release may contain forward-looking statements, which speak only as of the date hereof and are based upon our current expectations and the information available to us at this time. Words such as "believes," "anticipates," "expects," "intends," "plans," "seeks," "estimates," "may," "should," "will," "can," and variations of these words or similar expressions are intended to identify forward-looking statements. These statements include, but are not limited to, statements about our consulting services and statements about the awarded on-call contract. Such statements are not guarantees of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict, and actual results could differ materially and adversely from those expressed in any forward-looking statements as a result of various factors.

Important factors that may cause such a difference include, but are not limited to, our ability to successfully perform the services cost effectively; agency budgetary constraints; utilization needs of the agency for the services subject to the contract (e.g., seasonality); performance timing and cancellation of task orders; and the potential impact of product and service offerings from competitors. Further information on Iteris, Inc., including additional risk factors that may affect our forward-looking statements, is contained in our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q, our Current Reports on Form 8-K, and our other SEC filings that are available through the SEC's website (www.sec.gov).


These press releases may also interest you

at 06:15
Overall 8.46 Average Revised Venous Clinical Severity Score (rVCSS) Improvement Per Patient for Patients Showing Clinical Meaningful Benefit (rVCSS Improvement ≥ 3 Points) including:9.29 Points for Patients at the Two-Year Milestone8.08 Points...

at 06:13
Synchrony Financial today announced its first quarter 2024 results for the period ending March 31, 2024. The earnings news release, financial tables and related materials can be found on the company's investor relations website...

at 06:10
Thermo Fisher Scientific Inc. , the world leader in serving science, will hold its 2024 Investor Day on Thursday, September 19, starting at 9:00 a.m. (ET) in New York City. The format will feature presentations by members of Thermo Fisher...

at 06:05
OSARO, a global leader in machine-learning-enabled robotics for e-commerce, announced the appointment of industry veteran Brent Barcey as senior vice-president of corporate development. Barcey brings 25 years of experience growing global businesses...

at 06:05
Thermo Fisher Scientific Inc. , the world leader in serving science, today reported its financial results for the first quarter ended March 30, 2024. First Quarter 2024 Highlights First quarter revenue was $10.34 billion. First quarter GAAP...

at 06:05
Biodesix, Inc. , a leading diagnostic solutions company with a focus in lung disease, announced today that it will release financial results for the first quarter ended March 31, 2024 after the close of trading on Wednesday, May 8. Biodesix's...



News published on and distributed by: